Examination of efficacy and safety of long-term administration of elobixibat in hemodialysis patients with chronic constipatio
Not Applicable
Recruiting
- Conditions
- Chronic constipation complicated with chronic renal disease
- Registration Number
- JPRN-UMIN000049865
- Lead Sponsor
- Hyakutake Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 55
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who had a history of hypersensitivity of elobixibat 2. Patients who are confirmed or suspected intestinal obstruction due to tumor, hernia etc. 3. Patients who are suspected constipation due to organic disease 4. Patients who participated in clinical trials or intervention studies during the observation period
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of spontaneous bowel movement frequency before the start of administration and at the last observation after Week 24 of administration
- Secondary Outcome Measures
Name Time Method